Influence of Body Mass Index on the Clinicopathological Features of Papillary Thyroid Carcinoma in a Chinese Population
Metabolic Syndrome and Related Disorders · 2025
DOI: 10.1089/met.2024.0148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolic Syndrome and Related Disorders, 2025. Verfasst von Li Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China. Hauptthemen laut MEDLINE: Thyroid Cancer, Papillary, Body Mass Index, Thyroid Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
Background
Previous studies suggested a relationship between obesity and a high risk of thyroid cancer. However, the association between high body mass index (BMI) and the aggressiveness of papillary thyroid carcinoma (PTC) is controversial. In this study, we aimed to investigate the impact of excess BMI on histopathologic aggressiveness of PTC in a Chinese population.
Methods
Between January 2015 and September 2020, 4369 PTC patients who were tested for BRAF mutation at Jiangyuan Hospital were enrolled. Logistic regression analyses were used to evaluate the associations between BMI and clinicopathological features of PTC as well as tumor BRAF mutational status.
Results
Of 4369 PTC patients, the mean BMI was 24.06 ± 3.49 kg/m2, and BRAFV600E mutations were detected in 3528 (80.8%) patients. BMI ≥24.0 at initial surgery was associated with tumor multifocality and bilaterality, but not with advanced tumor stage, extrathyroidal extension (ETE), ratio of positive lymph nodes >0.3, distant metastasis, or BRAFV600E mutation.
Conclusion
Our present study suggested that compared to patients with a normal BMI, overweight and obese patients had a greater risk of multifocality and bilaterality of PTC. No significant associations were observed between higher BMI and the more advanced tumor-node-metastasis stage or BRAFV600E mutational status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China.
- Department of Radiopharmaceuticals, School of Pharmacy, Nanjing Medical University, Nanjing, China.
- School of Life Science and Technology, Southeast University, Nanjing, China.
ORCID-Profile: Li Zhang
Zitieren
APA
Zhang, L., Xu, S., Cheng, X., Zhu, Y., Cai, G., Wu, J., Gao, W., Bao, J., & Yu, H. (2025). Influence of Body Mass Index on the Clinicopathological Features of Papillary Thyroid Carcinoma in a Chinese Population. Metabolic Syndrome and Related Disorders. https://doi.org/10.1089/met.2024.0148
Vancouver
Zhang L, Xu S, Cheng X, Zhu Y, Cai G, Wu J, et al. Influence of Body Mass Index on the Clinicopathological Features of Papillary Thyroid Carcinoma in a Chinese Population. Metabolic Syndrome and Related Disorders. 2025. doi:10.1089/met.2024.0148
BibTeX
@article{Zhang2025,
author = {Zhang, Li and Xu, Shichen and Cheng, Xian and Zhu, Yun and Cai, Gangming and Wu, Jing and Gao, Wenjing and Bao, Jiandong and Yu, Huixin},
title = {Influence of Body Mass Index on the Clinicopathological Features of Papillary Thyroid Carcinoma in a Chinese Population},
journal = {Metabolic Syndrome and Related Disorders},
year = {2025},
doi = {10.1089/met.2024.0148}
}
EUVIMED